The predictive model developed using these datasets could differentiate benign and malignant lesions with 78% accuracy, 83.6% sensitivity and 71.5% specificity. A pilot study of 173 female study subjects is underway, in order to validate this predictive model in an independent test population.
that matches the numbers on CyrcadianHealth's website for the data cherry-picked from the "initial Phase I, II, and population studies: http://cyrcadiahealth.com/core-technology/
As for the assertion that the "Data processing center is a work in progress..." says who? And where is it located physically? Call CyrcadiaHealth and nobody answers, but you can leave a message -- does it even exist outside of a voicemail box?